Literature DB >> 23450548

Pessaries (mechanical devices) for pelvic organ prolapse in women.

Carol Bugge1, Elisabeth J Adams, Deepa Gopinath, Fiona Reid.   

Abstract

BACKGROUND: Pelvic organ prolapse is common, with some degree of prolapse seen in up to 50% of parous women in a clinic setting, although many are asymptomatic. The use of pessaries (a passive mechanical device designed to support the vagina) to treat prolapse is very common, and up to 77% of clinicians use pessaries for the first line management of prolapse. A number of symptoms may be associated with prolapse and treatments include surgery, pessaries and conservative therapies. A variety of pessaries are described which aim to alleviate the symptoms of prolapse and avert or delay the need for surgery.
OBJECTIVES: To determine the effectiveness of pessaries (mechanical devices) for pelvic organ prolapse. SEARCH
METHODS: We searched the Cochrane Incontinence Group Specialised Register of trials (searched 13 March 2012), which includes searches of CENTRAL, MEDLINE, PREMEDLINE and handsearching of conference proceedings, and handsearched the abstracts of two relevant conferences held in 2011. We also searched the reference lists of relevant articles. SELECTION CRITERIA: Randomised and quasi-randomised controlled trials which included a pessary for pelvic organ prolapse in one arm of the study. DATA COLLECTION AND ANALYSIS: Abstracts were assessed independently by two authors with arbitration from a third if necessary. Data extraction was completed independently for included studies by two review authors. MAIN
RESULTS: To date there is only one published randomised controlled trial assessing the use of pessaries in the treatment of pelvic organ prolapse. AUTHORS'
CONCLUSIONS: The review authors identified one randomised controlled trial comparing ring and Gellhorn pessaries. The results of the trial showed that both pessaries were effective for the approximately 60% of women who completed the study with no significant differences identified between the two types of pessary. However, methodological flaws were noted in the trial, as elaborated under risk of bias assessment. There is no consensus on the use of different types of device, the indications nor the pattern of replacement and follow-up care. There is an urgent need for randomised studies to address the use of pessaries in comparison with no treatment, surgery and conservative measures.

Entities:  

Mesh:

Year:  2013        PMID: 23450548      PMCID: PMC7173753          DOI: 10.1002/14651858.CD004010.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  35 in total

1.  Impact on quality of life after ring pessary use for pelvic organ prolapse.

Authors:  Tarinee Manchana; Suvit Bunyavejchevin
Journal:  Int Urogynecol J       Date:  2012-01-06       Impact factor: 2.894

2.  GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology.

Authors:  Gordon H Guyatt; Andrew D Oxman; Holger J Schünemann; Peter Tugwell; Andre Knottnerus
Journal:  J Clin Epidemiol       Date:  2010-12-24       Impact factor: 6.437

Review 3.  The aetiology of prolapse.

Authors:  H P Dietz
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-08-02

4.  Evaluation of vaginal pessary management: a UK-based survey.

Authors:  M Gorti; G Hudelist; A Simons
Journal:  J Obstet Gynaecol       Date:  2009-02       Impact factor: 1.246

Review 5.  The history and usage of the vaginal pessary: a review.

Authors:  Reeba Oliver; Ranee Thakar; Abdul H Sultan
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2011-01-21       Impact factor: 2.435

6.  Vaginal pessaries in managing women with pelvic organ prolapse and urinary incontinence: patient characteristics and factors contributing to success.

Authors:  Lesley-Ann M Hanson; Jane A Schulz; Catherine G Flood; Bonita Cooley; Florence Tam
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-07-26

7.  Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders.

Authors:  M D Barber; M N Kuchibhatla; C F Pieper; R C Bump
Journal:  Am J Obstet Gynecol       Date:  2001-12       Impact factor: 8.661

8.  The prevalence of pelvic floor disorders and their relationship to gender, age, parity and mode of delivery.

Authors:  A H MacLennan; A W Taylor; D H Wilson; D Wilson
Journal:  BJOG       Date:  2000-12       Impact factor: 6.531

9.  The distribution of pelvic organ support in a population of female subjects seen for routine gynecologic health care.

Authors:  S E Swift
Journal:  Am J Obstet Gynecol       Date:  2000-08       Impact factor: 8.661

10.  Conservative versus surgical management of prolapse: what dictates patient choice?

Authors:  Dharmesh S Kapoor; Ranee Thakar; Abdul H Sultan; Reeba Oliver
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-06-19
View more
  31 in total

1.  Comments on Lone et al.: One-year prospective comparison of vaginal pessaries and surgery for pelvic organ prolapse using the validated ICIQ-VS and ICIQ-UI (SF) questionnaires.

Authors:  Kim van de Waarsenburg; Astrid Vollebregt; Fred Milani; Katrien Oude Rengerink; Huub van der Vaart
Journal:  Int Urogynecol J       Date:  2015-08-04       Impact factor: 2.894

Review 2.  An integrative review and severity classification of complications related to pessary use in the treatment of female pelvic organ prolapse.

Authors:  Marwa Abdulaziz; Lynn Stothers; Darren Lazare; Andrew Macnab
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

3.  Health Care Disparities Among English-Speaking and Spanish-Speaking Women With Pelvic Organ Prolapse at Public and Private Hospitals: What Are the Barriers?

Authors:  Alexandriah N Alas; Gena C Dunivan; Cecelia K Wieslander; Claudia Sevilla; Biatris Barrera; Rezoana Rashid; Sally Maliski; Karen Eilber; Rebecca G Rogers; Jennifer Tash Anger
Journal:  Female Pelvic Med Reconstr Surg       Date:  2016 Nov/Dec       Impact factor: 2.091

4.  Surgical interventions for uterine prolapse and for vault prolapse: the two VUE RCTs.

Authors:  Christine Hemming; Lynda Constable; Beatriz Goulao; Mary Kilonzo; Dwayne Boyers; Andrew Elders; Kevin Cooper; Anthony Smith; Robert Freeman; Suzanne Breeman; Alison McDonald; Suzanne Hagen; Isobel Montgomery; John Norrie; Cathryn Glazener
Journal:  Health Technol Assess       Date:  2020-03       Impact factor: 4.014

5.  Interventions for treating recurrent stress urinary incontinence after failed minimally invasive synthetic midurethral tape surgery in women.

Authors:  Evangelia Bakali; Eugenie Johnson; Brian S Buckley; Paul Hilton; Ben Walker; Douglas G Tincello
Journal:  Cochrane Database Syst Rev       Date:  2019-09-04

Review 6.  A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy.

Authors:  Mariana S Sousa; Michelle Peate; Sherin Jarvis; Martha Hickey; Michael Friedlander
Journal:  Ther Adv Med Oncol       Date:  2017-01-31       Impact factor: 8.168

7.  Natural history of pessary use in women aged 65 - 74 versus 75 years and older with pelvic organ prolapse: a 12-year study.

Authors:  Sophie Ramsay; Le Mai Tu; Cara Tannenbaum
Journal:  Int Urogynecol J       Date:  2016-02-12       Impact factor: 2.894

8.  Pessary types and discontinuation rates in patients with advanced pelvic organ prolapse.

Authors:  Birte Wolff; Kathryn Williams; Allen Winkler; Lawrence Lind; Dara Shalom
Journal:  Int Urogynecol J       Date:  2016-12-10       Impact factor: 2.894

9.  Clinical Profile of Uterine Prolapse Cases in South India.

Authors:  Nitin Joseph; Chidambara Krishnan; B Ashish Reddy; Nurul Afiqah Adnan; Low Mei Han; Yeoh Jing Min
Journal:  J Obstet Gynaecol India       Date:  2015-10-16

10.  Effect of vaginal estrogen on pessary use.

Authors:  Sybil G Dessie; Katherine Armstrong; Anna M Modest; Michele R Hacker; Lekha S Hota
Journal:  Int Urogynecol J       Date:  2016-03-18       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.